Meiragtx Holdings vs Pharming Group
Pharming Group is the larger business, with $376m of revenue in fiscal 2025 against $81.4m for Meiragtx Holdings (4.6 times as much). Meiragtx Holdings grew faster (144.6% against 26.6%). Pharming Group kept more of each dollar of sales as profit: a net margin of 0.8% against -140.3%.
| Latest fiscal year | Meiragtx HoldingsMGTX, 2025 | Pharming GroupPHAR, 2025 |
|---|---|---|
| Revenue | $81.4m | $376m |
| Revenue growth | 144.6% | 26.6% |
| Net income | −$114m | $2.9m |
| Operating margin | -130.2% | 6.9% |
| Net margin | -140.3% | 0.8% |
| Return on equity | — | 1.1% |
| Free cash flow | −$50.2m | $54.0m |
| Cash | $65.9m | $145m |
| Total debt | $74.3m | $98.1m |
| Debt to equity | — | 35.4% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 403 | — |
| Market value | $887m | $898m |
| Price vs our value range | — | Above our value range |
| Moat score | 9 (Weak) | — |
| Insider trades, 12 months | 0 buys, 10 sales | 0 buys, 0 sales |